About this trial
The aim of this study is to compare the postoperative analgesic efficacy of bilateral erector spinae plane block and bilateral external oblique-intercostal plane block in patients undergoing open ventral hernia repair.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients scheduled for open ventral hernia repair under general anesthesia
Patients with ASA scores (American Society of Anesthesiologists) 1 and 2
Patients with a body mass index between 18.5 and 34.9
Disqualifiers
Patients scheduled for open ventral hernia repair under spinal or epidural anesthesia
Patients who have previously undergone spine surgery.
Patients with known local anesthetic allergy
Pregnant women
Trial design
Parallel
Treatments tested in this trial
Erector Spine Plane Block
Procedure/SurgeryBilateral erector spinae plane block was performed under aseptic conditions at the T7 vertebral level using ultrasound guidance with a convex probe. An 80-mm peripheral nerve block needle was inserted 3-4 cm lateral to the midline with an in-plane approach to the fascial plane deep to the erector spinae muscle. After negative aspiration and hydrodissection with 1-3 ml of saline, 30 ml of 0.25% bupivacaine was injected on each side, with craniocaudal spread confirmed by ultrasound. Patients were then positioned for surgery.
External Oblique - Intercostal Plane Block
Procedure/SurgeryBilateral external oblique-intercostal plane block was performed under aseptic conditions by identifying the 6th and 7th ribs along the midclavicular line. Using ultrasound guidance with the probe placed parallel to the midclavicular line, the ribs, intercostal muscles, external oblique muscle, and pleura were visualized. A 50-mm block needle was advanced craniocaudally into the plane between the external oblique and intercostal muscles. After negative aspiration and hydrodissection with 1-3 ml saline, 30 ml of 0.25% bupivacaine was injected on each side, with craniocaudal spread confirmed by ultrasound. Patients were then positioned for surgery.
Treatment groups
Trial outcomes
Primary outcomes
Tramadol Consumption
The primary endpoint of the study was whether tramadol consumption in the first 24 hours was significantly different between groups.
Secondary outcomes
Remifentanil Consumption
The amount of remifentanil consumption required to maintain normal vital signs during the intraoperative period.
Other outcomes
Pain Scores
Difference between pain scores according to Visual Analog Scale at the 2nd and 24th postoperative hours. This scale consists of a 100-millimeter line, with 0 representing no symptoms and 100 representing the most severe symptoms ever experienced. Patients are asked to mark the intensity they feel on the line. A numerical value is then obtained by measuring the millimeter at which the mark appears.
Additional Analgesia
The time when patients request painkiller for the first time despite their existing analgesia plan.
Nausea and Vomiting
Nausea and vomiting according to Visual Analog Scale that can be observed at the 2nd and 24th postoperative hours.This scale consists of a 100-millimeter line, with 0 representing no symptoms and 100 representing the most severe symptoms ever experienced. Patients are asked to mark the intensity they feel on the line. A numerical value is then obtained by measuring the millimeter at which the mark appears.
Gas and Stool
Time to pass gas or stool for the first time in the postoperative period.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: